1. Home
  2. OVLY vs MDWD Comparison

OVLY vs MDWD Comparison

Compare OVLY & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oak Valley Bancorp (CA)

OVLY

Oak Valley Bancorp (CA)

N/A

Current Price

$27.75

Market Cap

219.0M

Sector

Finance

ML Signal

N/A

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$18.45

Market Cap

230.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVLY
MDWD
Founded
1990
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
219.0M
230.7M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
OVLY
MDWD
Price
$27.75
$18.45
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$37.50
AVG Volume (30 Days)
8.4K
87.3K
Earning Date
01-23-2026
11-20-2025
Dividend Yield
2.13%
N/A
EPS Growth
N/A
N/A
EPS
2.84
N/A
Revenue
$79,783,000.00
$20,932,000.00
Revenue This Year
N/A
$15.89
Revenue Next Year
N/A
$25.33
P/E Ratio
$9.74
N/A
Revenue Growth
2.98
6.15
52 Week Low
$22.70
$14.14
52 Week High
$32.24
$22.51

Technical Indicators

Market Signals
Indicator
OVLY
MDWD
Relative Strength Index (RSI) 52.73 55.38
Support Level $27.66 $17.23
Resistance Level $28.25 $18.86
Average True Range (ATR) 0.45 0.76
MACD -0.04 0.08
Stochastic Oscillator 68.28 82.09

Price Performance

Historical Comparison
OVLY
MDWD

About OVLY Oak Valley Bancorp (CA)

Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: